(Q52020246)

19 April 2018

title

Use of human CD4 transgenic mice for studying immunogenicity of HIV-1 envelope protein gp120. (English)

1 reference

19 April 2018

author name string

J Seagal

1

1 reference

19 April 2018

E Spectorman

2

1 reference

19 April 2018

J M Gershoni

3

1 reference

19 April 2018

G F Denisova

4

1 reference

19 April 2018

publication date

1 April 2001

1 reference

19 April 2018

published in

Transgenic Research

1 reference

19 April 2018

volume

10

1 reference

19 April 2018

issue

2

1 reference

19 April 2018

page(s)

113-120

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1023/a:1008941713904

exact match

0 references

cites work

Manipulating the genome to study reproduction. Mice with 'humanized' zonae pellucidae.

1 reference

12 December 2020

Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst-case dynamic analysis

1 reference

12 December 2020

HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex

1 reference

12 December 2020

Escape of human immunodeficiency virus from immune control

1 reference

12 December 2020

Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice

1 reference

12 December 2020

Interpretation of phenotype in genetically engineered mice

1 reference

12 December 2020

Human CD4 restores normal T cell development and function in mice deficient in murine CD4.

1 reference

12 December 2020

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

12 December 2020

Interleukin-2 receptor beta and gamma chain dysregulation during the inhibition of CD4 T cell activation by human immunodeficiency virus-1 gp120.

1 reference

12 December 2020

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

12 December 2020

T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host

1 reference

12 December 2020

Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection

1 reference

12 December 2020

The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection

1 reference

12 December 2020

An ongoing immune response to HIV envelope gp120 in human CD4-transgenic mice contributes to T cell decline upon intravenous administration of gp120

1 reference

12 December 2020

Reconstitution of the subclass-specific expression of CD4 in thymocytes and peripheral T cells of transgenic mice: identification of a human CD4 enhancer

1 reference

12 December 2020

Inhibitory effect of interleukin-16 on interleukin-2 production by CD4+ T cells

1 reference

12 December 2020

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

12 December 2020

HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71)

1 reference

12 December 2020

A murine model of myocardial microvascular thrombosis

1 reference

12 December 2020

Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.

1 reference

12 December 2020

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

12 December 2020

Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes

1 reference

12 December 2020

Tyrosine phosphorylation induced by C4 peptide constructs from HIV Gp120.

1 reference

12 December 2020

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

1 reference

12 December 2020

Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients

1 reference

12 December 2020

Spontaneous and engineered mutant mice as models for experimental and comparative pathology: history, comparison, and developmental technology.

1 reference

12 December 2020

Why do we not have an HIV vaccine and how can we make one? .

1 reference

12 December 2020

Genetic control of the immune response to HIV type 1 envelope glycoprotein 120 in mice: effects of MHC and transgenic human CD4.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008941713904

1 reference

19 April 2018

1 reference

19 April 2018